Pulmonary Embolism Score

Wells score, GENEVA, PERC rule

Veröffentlicht von: Putu Angga Risky Raharja

Beschreibung

"Pulmonary Embolism Score: Wells, GENEVA, PERC rule" is a mobile app designed to help health practitioner to determine the risk of pulmonary embolism by using the Wells criteria or Wells score, GENEVA score, and PERC rule. The Wells criteria for pulmonary embolism is a risk stratification score and clinical decision rule to estimate the probability for acute pulmonary embolism in patients in which history and examination suggest acute pulmonary embolism is a diagnostic possibility. As with all clinical decision aids, the physician must first have a suspicion of the diagnosis before attempting to apply the Wells criteria. History taking and exam should always be performed prior to using the "Pulmonary Embolism Score: Wells, GENEVA, PERC rule" app.
There are several features of "Pulmonary Embolism Score: Wells, GENEVA, PERC rule", namely:
- Simple and very easy to use.
- Precise calculation with Wells criteria or Wells score.
- Simple and straightforward calculation of GENEVA score.
- PERC rule for ruling out pulmonary embolism.
- Risk calculation of acute pulmonary embolism in a patient with dyspnea or shortness of breath
- It is totally free. Download now!
Aside from Wells score, “Pulmonary Embolism Score: Wells, GENEVA, PERC rule” app also has other scores, namely GENEVA score and PERC rule. The Revised GENEVA scores, along with the Wells score are the most commonly used scores to evaluate for pulmonary embolism. Some physicians prefer the Revised Geneva score because of its objectivity While in the patient considered low-risk of pulmonary embolism, PERC rule may help avoid further testing.
Disclaimer: All calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this "Pulmonary Embolism Score: Wells, GENEVA, PERC rule" app might be different from your local practice. Consult with an expert doctor whenever necessary.
Ausblenden Mehr anzeigen...

Screenshots

Pulmonary Embolism Score Häufige Fragen

  • Ist Pulmonary Embolism Score kostenlos?

    Ja, Pulmonary Embolism Score ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist Pulmonary Embolism Score seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet Pulmonary Embolism Score?

    Pulmonary Embolism Score ist kostenlos.

  • Wie hoch ist der Umsatz von Pulmonary Embolism Score?

    Um geschätzte Einnahmen der Pulmonary Embolism Score-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Taiwan noch nicht bewertet.
Bewertungsverlauf

Pulmonary Embolism Score Bewertungen

Keine Bewertungen in Taiwan
Die App hat noch keine Bewertungen in Taiwan.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
App ist noch nicht gerankt

Pulmonary Embolism Score Konkurrenten

Name
Pulmonology and Allergy
Clinical Decision Support Tool
COPD @Point of Care™
PFT eval
guidance on spirometry & PFT's
ATS Journals App
Rad Rounds UIP to IPF
Chest Pain Score - RESCA
Chest Pain Score
IPF Manager
Idiopathic Pulmonary Fibrosis
AABIP iPASS
phaware
iBronch
Video Bronchoscopy

Pulmonary Embolism Score Installationen

Letzte 30 Tage

Pulmonary Embolism Score Umsatz

Letzte 30 Tage

Pulmonary Embolism Score Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von Pulmonary Embolism Score mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.